Free Trial
NASDAQ:SIOX

Sio Gene Therapies (SIOX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.45
$0.48
50-Day Range
$0.38
$0.48
52-Week Range
$0.25
$0.50
Volume
40,400 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SIOX stock logo

About Sio Gene Therapies Stock (NASDAQ:SIOX)

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.

SIOX Stock News Headlines

Sio Gene Therapies Inc SIOX
5 Stocks that could triple in a week
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.
Sio Gene Therapies (NASDAQ: AXGT)
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
SIOX Sio Gene Therapies Inc.
Following layoffs, gene therapy firm leaves Durham
Sio Gene Therapies Inc. (SIOX)
See More Headlines
Receive SIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sio Gene Therapies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/12/2021
Today
7/26/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SIOX
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
No Data
Beta
1.05
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. David W. Nassif J.D. (Age 70)
    CEO, CFO, Chief Accounting Officer, General Counsel & Director
    Comp: $699.52k

SIOX Stock Analysis - Frequently Asked Questions

How were Sio Gene Therapies' earnings last quarter?

Sio Gene Therapies Inc. (NASDAQ:SIOX) posted its quarterly earnings data on Friday, November, 12th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.12.

When did Sio Gene Therapies' stock split?

Sio Gene Therapies shares reverse split on Wednesday, May 8th 2019. The 1-8 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

This page (NASDAQ:SIOX) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners